Billionaire Joseph Edelman's Top 10 Long-Term Stock Picks
Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology and healthcare investing.
Aldeyra Therapeutics Inc. (ALDX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 9,275,851 | $53,336,143 | 1.88% | |
| 2. | Knoll Capital Management Fred Knoll | 5,475,516 | $31,484,217 | 20.48% | |
| 3. | Ardsley Partners Philip Hempleman | 1,750,000 | $9,888,200 | +53% | 1.89% |
| 4. | Kingdon Capital Mark Kingdon | 779,000 | $4,479,250 | 0.47% | |
| 5. | 683 Capital Partners Ari Zweiman | 476,000 | $2,737,001 | +65% | 0.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.13 | 509 | $5,156.17 | 922 | 2023-04-12 | Filing | |
| $12.81 | 413 | $5,290.53 | 413 | 2021-05-03 | Filing | |
| $4.74 | 37,712 | $178,754.88 | 9,275,851 | 2024-04-05 | Filing | |
| $4.67 | 140,281 | $655,112.27 | 9,238,139 | 2024-04-04 | Filing | |
| $4.09 | 309,847 | $1,267,274.23 | 9,097,858 | 2024-04-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.42 | 3,400,000 | $4,828,000.00 | 5,875,851 | 2025-04-03 | Filing | |
| $4.74 | 16,041 | $75,974.99 | 236,771 | 2024-08-12 | Filing | |
| $4.74 | 10,834 | $51,313.07 | 126,382 | 2024-08-12 | Filing | |
| $3.16 | 11,537 | $36,503.07 | 252,812 | 2024-03-12 | Filing | |
| $3.41 | 13,201 | $44,967.89 | 130,154 | 2024-03-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,736,038 | $21,482,219 | 0% | |
| 2. | 3,718,018 | $21,378,604 | 0% | |
| 3. | 348,521 | $10,026,040 | 0% | |
| 4. | 1,233,414 | $7,092,130 | 0.17% | |
| 5. | 1,137,828 | $6,544,126 | 0% |
News See All
Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory
We came across a bullish thesis on Aldeyra Therapeutics Inc (ALDX) on ValueInvestorsClub by MrStingy. In this article we will summarize the bulls' thesis on ALDX.
13 Hot Penny Stocks To Buy According to Hedge Funds
The overall market optimism helped by expectations that the Fed might start cutting interest rates in 2024 is helping riskier assets and equities, including small-cap stocks, penny stocks and cryptocurrencies...
15 Most Shorted Stocks That Are Loved By Analysts
In this piece, we will take a look at the 15 most shorted stocks that are loved by analysts.
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics Full Year 2022 Financial Results Conference Call.
5 Pharmaceutical Stocks to Buy According to Lawrence Hawkins' Prosight Capital
In this article, we discuss 5 pharmaceutical stocks to buy according to Lawrence Hawkins' Prosight Capital.
Is Aldeyra Therapeutics Inc (ALDX) A Good Stock To Buy?
A whopping number of 13F filings filed with U.S.
Hedge Fund and Insider Trading News: Ray Dalio, Paul Singer, David Einhorn, Tiger Global Management, Zoom Video Communications Inc (ZM), Aldeyra Therapeutics Inc (ALDX), and More
Bridgewater Associates founder Ray Dalio called for a bipartisan solution to reviving the post-pandemic economy. The U.S.
Hedge Fund and Insider Trading News: Warren Buffett, Pantera Capital, Alta Fox Capital Management, Canadian National Railway (CNI), Cloudflare Inc (NET), and More
New details from Pantera Capital, an expenditure agency and hedge fund, implies that Bitcoin’s (BTC) current cost motion is intently next the stock-to-adhere to model’s trajectory and the firm’s...
Is ALDX A Good Stock To Buy Now?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.